Novavax received clearance from the FDA to move forward with phase 3 clinical trials for its COVID-19-influenza combination (CIC ... confirming that the event was not related to the investigational ...

At the same time, the current COVID-19 vaccine season initiated three weeks earlier in the ... including both KP.3.1.1 and XEC. Please turn to Slide 14. This slide shows neutralizing antibody ...

New preclinical data demonstrates that CMV antigens identified with Evaxion’s AI-Immunology™ platform trigger targeted immune responses Results ...

Nov 12 (Reuters) - Novavax (NVAX.O), opens new tab cut its annual revenue forecast on Tuesday, citing lower-than-expected ...

The seasonal COVID-19 spike, combined with rising cases of seasonal flu and RSV, brings what has been called a “tripledemic.” ...

Novavax (NVAX) announced that the U.S. FDA has removed the clinical hold on Novavax’s Investigational New Drug application for its ...

Novavax said the Food and Drug Administration allowed it to continue testing a combination COVID-19-flu and standalone flu vaccine that had been put on hold.

There is currently no vaccine available ... omicron variant XEC rising as a fast-spreading variant slated to take over as the ...

Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...

Ireland has reported a significant increase in cases of the new XEC Covid variant, now accounting for 20.6% of cases in ...

The latest coronavirus strain, XEC, makes up 17%. It is another descendant from the ... insurance provider as we cannot ...